Please assess the completion status of the following clinical trial:

Trial Title: A Study Comparing Insulin Intensification Therapies in Patients With Type 2 Diabetes Mellitus

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Present with type 2 diabetes mellitus~* Have been receiving twice-daily premixed insulin therapy with or without metformin and/or alpha-glucosidase inhibitors, for at least six months prior to study entry~* Have Haemoglobin A1c (HbA1c) \>7.0% and \<12.0%~Exclusion Criteria:~* Within the last 3 months prior to entry into the study, are taking any non-permitted glucose-lowering agents, or are taking any non-permitted oral antihyperglycaemic medications~* Are pregnant or intend to become pregnant during the course of the study, or are sexually active women of childbearing potential not actively practicing birth control by a method determined by the investigator to be medically acceptable.~* Are women who are breastfeeding.~* Have an irregular sleep/wake cycle (for example, participants who sleep during the day and work during the night).~* Do not regularly consume three meals per day.~* Have a body mass index \>35 kilogram per square meter (kg/m\^2).~* Have had more than one episode of severe hypoglycaemia within 24 weeks prior to entry into the study.~* Have cardiac disease with a functional status that is Class III or IV~* Have a history of renal or liver disease~* Have used less than or equal to 20 Units per day (U/day) of insulin during the past 90 days for more than 14 days (accumulated).

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Premixed Insulin (Type: EXPERIMENTAL): Twice daily (before breakfast and lunch) insulin lispro mix 50 (50% insulin lispro, 50% insulin lispro protamine suspension \[LM50\]) and once daily (before dinner) insulin lispro mix 25 (25% insulin lispro, 75% insulin lispro protamine suspension \[LM25\])
- Basal-Bolus (Type: ACTIVE_COMPARATOR): Once daily (bedtime) insulin glargine and three pre-meal insulin lispro

Based on this trial design, predict the completion outcome and termination type (if applicable).